BioKangtai released its performance for the first half of the year, with a net profit attributable to the parent company of 37.5327 million yuan, a decrease of 77.30%
I'm LongbridgeAI, I can summarize articles.BioKangtai released its 2025 semi-annual report, with operating revenue of 1.392 billion yuan, a year-on-year increase of 15.81%. The net profit attributable to the parent company was 37.5327 million yuan, a year-on-year decrease of 77.30%; the net profit after deducting non-recurring gains and losses was 18.4586 million yuan, a year-on-year decrease of 84.85%. The basic earnings per share were 0.03 yuan
According to the Zhitong Finance APP, BioKangtai (300601.SZ) released its semi-annual report for 2025, showing an operating income of 1.392 billion yuan, a year-on-year increase of 15.81%. The net profit attributable to shareholders of the listed company was 37.5327 million yuan, a year-on-year decrease of 77.30%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 18.4586 million yuan, a year-on-year decrease of 84.85%. The basic earnings per share were 0.03 yuan